• About us
• Contact

Advertisement

Organisation › Details

Kreaxi (Group)

Formed by the merger of Rhône-Alpes Création and Banexi Ventures Partners, KREAXI is one of the French leaders in venture capital, totaling over €500 million ($540M) in funding raised from public and private investors. Launched in 1989, KREAXI’s regional activity has accompanied over 280 Auvergne-Rhône-Alpes companies – with recent successes such as Erytech Pharma, Nanobiotix, Amoeba, PX Therapeutics or Docea Power – taking a stake at an early stage to finance their initial development phases. With €69 million ($74.5M) in funds under management thanks to the support of the Auvergne-Rhône-Alpes region, Bpifrance, regional banks and industrial groups, Kreaxi plays a key role in financing seed and creation phases. It manages a portfolio of around fifty shareholdings through its three funds (RAC I, RAC II and R2V), with an active staff of nine. *

 

	Start	2017-03-28 merged before
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Region	Paris
	Country	France
	Street	13–15 rue Taitbout
	City	75009 Paris
	Tel	+33-1-7302-8969
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	500,000,000 (funds, managed (2017) 2017-03-28)
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.